Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland

By Janaszek W.   Gay N.J.   Gut W.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 473-478

Elsevier

Access to resources Recommend Favorite

Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age *

By Klinge  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3134-3140

Elsevier

Access to resources Recommend Favorite

Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates

By Stittelaar K.J.   Vos H.W.   van Amerongen G.   Kersten G.F.A.   Osterhaus A.D.M.E.   de Swart R.L.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 155-157

Elsevier

Access to resources Recommend Favorite

A comparison of alternate immunization regimes for measles in vaccinated populations

By Pabst H.F.   Boothe P.M.   Carson M.M.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 182-192

Elsevier

Access to resources Recommend Favorite

Seroprevalence of neutralizing antibodies to measles virus in a vaccinated population in Iran, 1998

By Khodabandeh Loo M.   Sabahi F.   Soleimanjdahi H.   Kazemnejad A.   Roustai M.H.  

European Journal of Epidemiology, Vol. 18, Iss. 11, 2003-11 ,pp. : 1085-1089

Springer Publishing Company

Access to resources Recommend Favorite